• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Enforcement Report - Week of January 31, 2024

    FDA

    FDA warns of rise in reports of child poisonings linked to cough medicine

    NBC NEWS

    Puracap Pharm`s Generic Benzonatate Receives Approval in US

    FDA

    Aiping Pharm`s Generic Benzonatate Receives Approval in US

    FDA

    Enforcement Report - Week of May 31, 2017

    FDA

    American Health Packaging, Ongoing Class II recall of Benzonatate Capsules, USP, 100 mg, 100 count (10X10), Rx only, Packaged and Distributed by: American Health Packaging Columbus, Ohio 43217 --- NDC 68084-214-01(carton) NDC 68084-214-11 (individual dose) because of Failed Tablet/Capsule Specifications; recall initiated by manufacturer due to reports of wet capsules

    FDA

    Zydus Pharmaceuticals USA Inc, Ongoing Class II recall of Benzonatate Capsules, USP, 100 mg, Rx only, Manufactured by: Cadila Healthcare Ltd, Ahmedabad, India; Distributed by: Zydus Pharmaceuticals USA, In, Pennington, NJ USA 08534; 100-bottle capsules - NDC 68382-247-01 500-bottle capsules - NDC 68382-247-05 because of Failed Tablet/Capsule Specifications: Recall due to wet and/or leaking capsules.

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.